Table 2.
Clinical and biological characteristics of Adult T-cell Leukemia/Lymphoma (ATL) patients, diagnosed between 1st January 1983 and 31st March 2013, presenting with a survival superior to 10 years (long survival) in Martinique.
| Patient | Age (years) | Gender∗ | ATL type† | ADP‡ | SM§ | HM|| | CL# | Ss∗∗ | Hb∗∗∗ | PNΔ | Pltα | Lymβ | AbN lymγ (%) | Caδ | LDHε | Eosζ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 46 | F | chr | + | − | − | − | + | 11.7 | 3,1 | 192.0 | 10,1 | 58.0 | − | 1.0 | − |
| 2 | 40 | F | chr | − | − | − | + | − | 13.6 | 10,9 | 254.0 | 174,0 | 89.0 | − | 1.0 | + |
| 3 | 46 | F | chr | − | − | − | + | − | 7.3 | 4.3 | NK | 4,1 | NK | − | 2.1 | − |
| 4 | 50 | M | lym | + | − | − | + | + | 13.0 | 6.0 | 230.0 | 1,5 | 0.0 | − | 1.9 | + |
| 5 | 34 | M | lym | + | − | − | − | − | 9.7 | 0.9 | 127.0 | 1,5 | 0.0 | + | 2.6 | − |
| 6 | 62 | F | lym | − | − | + | + | − | 7.8 | 1.0 | 232.0 | 3,7 | 0.0 | − | 4.6 | + |
| 7 | 16 | F | chr | − | − | − | + | − | 11.5 | 2.0 | N | 3,6 | 9.0 | − | 1.0 | − |
| 8 | 36 | M | lym | + | − | − | + | − | 12.1 | 4,5 | 153.0 | 1,7 | 0.0 | + | 4.1 | − |
| 9 | 68 | M | chr | + | − | − | + | + | 12.9 | 3.6 | 154.0 | 2.4 | 33.0 | − | 1.1 | + |
| 10 | 45 | F | lym | + | − | − | + | − | N | N | N | N | 0.0 | − | 1.0 | − |
∗M: male, F: female, †chr:chronic – lym: lymphoma,‡ADP: adenomegaly, §SM: splenomegaly, ||HM: hepatomegaly, #CL: cutaneous lesions, ∗∗Ss: Strongyloides stercoralis, and ∗∗∗Hb: hemoglobin (g/dL).
ΔPN: polynuclear cells (1 × 109/L), αPlt: platelet (1 × 109/L), βLym: lymphocytes (1 × 109/L), γAbN lymph: abnormal lymphocytes (% of atypical lymphocytes relative to total lymphocytes), δCa: hypercalcemia, εLDH: lactate dehydrogenase (expressed as multiples of the normal value), ζEos: eosinophilia (1 × 109/L), +: presence, −: absence, N: within normal range, and NK: not known.